Moreover, Cr supplementation increased the p-IRS-1, GLUT2, and GLUT4 expression in the liver of various animal models of metabolic disorders, such as NAFLD, obesity, T2DM and metabolic syndrome, and thus lowering the hepatic TG levels of these models (23–27). Here, SLC2A2 is linked to metabolic dysfunction-associated steatotic liver disease.